Market Research Future published a Half-Cooked research report on “Peripheral Artery Disease Market Research Report – Global Forecast till 2025”– Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2025.
Peripheral Artery Disease Market Overview
Peripheral Artery Disease Market size is expected to exhibit significant growth over the forecast period. The market was valued at approximately USD 2.96 Billion in 2018 and is projected to register a 6.92% CAGR over the forecast period.
Atherosclerosis in the peripheral arteries remain the leading cause of peripheral artery disease. Atherosclerosis in associated with hardening of plaque that trigger clot formation in arteries, leading to their blockage.
Global demand for peripheral artery disease treatment has grown substantially in recent years. Availability of superior treatment and therapeutics for peripheral artery disease has reflected favourably on the market. Many market players have ramped up investment in R&D program to develop innovative treatment solution. The market is reaping benefits for increased R&D in healthcare. Data released by European Federation of Pharmaceutical Industries and Association reveals that in 2016 R&D investments in the Pharmaceutical Industry reached EUR 35000 Mn. The Centres for Disease Control and Prevention noted that in the U.S. per capita national health spending stood at USD 9,990 and the overall national health spending surpassed USD 3 trillion. High healthcare spending in advanced countries is viewed as key market driver.
Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/1540
The global peripheral artery disease market is also being influenced by factors such as increased occurrence of arterial diseases and associated complications, increase healthcare penetration, rising level of awareness, improve reimbursement policies and increasing geriatric population. However, formidable challenges lie ahead. Factors such as influx of fake drug, high risk oh infection and severe side-effects associated with treatment options somewhat derail the market growth.
Global Peripheral Artery Disease Market: Competition Analysis
- Braun Melsungen AG
- Boston Scientific Corporation
- TERUMO CORPORATION
- Sanofi S.A.
- AstraZeneca Plc.
- Bristol-Myers Squibb Company
- Merck & Co. Inc.
- Symic Bio Inc.
- CardioVascular BioTherapeutics Inc.
- Medtronic.
- KONINKLIJKE PHILIPS
- N.V. Proteon Therapeutics Inc.
- Smith & Nephew plc
- Bayer HealthCare Pharmaceuticals
- Zimmer Biomet Holdings Inc.
- Abbott
- Dickinson and Company (BD)
- Cook Medical
- Becton
- Johnson & Johnson Services Inc.
- Alcon Laboratories Inc.
- Angioscore Inc.
- Betagenon AB
- TheraVasc Inc.
- Aspen Surgical Products Inc.
- Stryker Corporation
- AnGes Inc.
- Cordis
Global Peripheral Artery Disease Market: Segmental Analysis
The segment analysis of the market has been conducted based on devices, drugs, and types of diseases.
Global Peripheral Artery Disease Market, by Disease Type
- Organic
- Functional
Global Peripheral Artery Disease Market, by Treatment Type
- Medications
- Angioplasty
- Bypass Grafting
- Atherectomy
- Thrombolytic Therapy
- Others
Global Peripheral Artery Disease Market, by End User
- Hospitals and Clinics
- Research and Academic Institutes
- Others
Global Peripheral Artery Disease Market: Regional Analysis
Regions covered in the report include Europe, the Middle East & Africa (MEA), Asia Pacific (APAC), and North America. A vast and robust healthcare sector in the U.S. makes North America a major market for peripheral artery disease treatment. Extensive healthcare penetration coupled with sound medical expertise and high medical healthcare expenditure. Additionally, rising patient pool is a key driver of the market in North America. Development of peripheral artery diseases is also linked with obesity and diabetes. The APAC peripheral artery disease market is also anticipated to witness a healthy growth over the next several years. Increased focus on improving the care quality propelling the market growth in the region. During the forecast period, the market in the region is expected to exhibit the highest growth.
Table Of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope Of The Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
…Continued
Browse the market data and information spread across 90 pages with 33 data tables and 49 figures of the report “Global Peripheral Artery Disease Market Research Report: By Disease Type (Organic and Functional), Treatment Type (Medications, Angioplasty, Bypass Grafting, Atherectomy, Thrombolytic Therapy and others), End User (Hospitals & Clinics, Research & Academic Institutes and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) – Forecast till 2025” in-depth alongside table of content (TOC) at: https://www.marketresearchfuture.com/reports/peripheral-artery-disease-market-1540
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
